Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tango Therapeutics, Inc.(TNGX) | 10,876,219 | 10,876,219 | 0 | $227.53M | $339.99M | 25.61% | +$112.46M |
| Revolution Medicines, Inc.(RVMD) | 500,000 | 500,000 | 0 | $48.63M | $93.64M | 7.05% | +$45.02M |
| ABIVAX Société AnonymeADS(ABVX) | 200,000 | 605,000 | +405,000 | $22.27M | $80.62M | 6.07% | +$58.35M |
| uniQure N.V.SHS(QURE) | 662,000 | 1,503,300 | +841,300 | $10.82M | $69.24M | 5.21% | +$58.42M |
| Kodiak Sciences Inc.(KOD) | 1,361,000 | 1,477,600 | +116,600 | $51.88M | $57.57M | 4.34% | +$5.69M |
| Kymera Therapeutics, Inc.(KYMR) | 329,100 | 429,100 | +100,000 | $27.41M | $49.20M | 3.71% | +$21.79M |
| Definium Therapeutics, Inc.(DFTX) | 598,500 | 998,500 | +400,000 | $11.31M | $46.97M | 3.54% | +$35.66M |
| Replimune Group, Inc.(REPL) | 1,175,000 | 3,983,000 | +2,808,000 | $8.99M | $44.09M | 3.32% | +$35.10M |
| Celcuity Inc.(CELC) | 225,000 | 416,530 | +191,530 | $25.68M | $43.58M | 3.28% | +$17.90M |
| Q32 Bio Inc.(QTTB) | 0 | 3,149,310 | +3,149,310 | $0 | $40.12M | 3.02% | +$40.12M |
| Capricor Therapeutics, Inc.(CAPR) | 590,000 | 1,395,156 | +805,156 | $17.94M | $33.60M | 2.53% | +$15.66M |
| Precigen, Inc.(PGEN) | 3,500,000 | 5,150,000 | +1,650,000 | $13.54M | $29.36M | 2.21% | +$15.81M |
| Corcept Therapeutics Incorporated(CORT) | 250,000 | 335,500 | +85,500 | $10.08M | $29.17M | 2.20% | +$19.09M |
| Surrozen, Inc.(SRZN) | 766,318 | 1,105,683 | +339,365 | $22.32M | $26.96M | 2.03% | +$4.64M |
| Protagonist Therapeutics Inc | 170,000 | 170,000 | 0 | $17.92M | $20.84M | 1.57% | +$2.92M |
| Vir Biotechnology, Inc.(VIR) | 1,866,000 | 1,866,000 | 0 | $16.72M | $19.01M | 1.43% | +$2.30M |
| Vaxcyte, Inc.(PCVX) | 325,000 | 325,000 | 0 | $18.89M | $18.89M | 1.42% | +$6.5K |
| UroGen Pharma Ltd.(URGN) | 500,000 | 500,000 | 0 | $8.99M | $18.40M | 1.39% | +$9.41M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,100,000 | 1,100,000 | 0 | $16.09M | $16.43M | 1.24% | +$341.0K |
| PTC Therapeutics, Inc.(PTCT) | 200,000 | 200,000 | 0 | $13.63M | $16.31M | 1.23% | +$2.69M |
| Praxis Precision Medicines, Inc.(PRAX) | 46,457 | 46,457 | 0 | $14.97M | $15.55M | 1.17% | +$585.4K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 800,000 | 800,000 | 0 | $11.12M | $14.37M | 1.08% | +$3.25M |
| Ocular Therapeutix, Inc.(OCUL) | 350,000 | 1,300,000 | +950,000 | $2.96M | $12.77M | 0.96% | +$9.80M |
| Opus Genetics, Inc.(IRD) | 2,250,000 | 2,815,000 | +565,000 | $10.24M | $11.57M | 0.87% | +$1.33M |
| Palisade Bio, Inc.(PALI) | 4,799,875 | 4,799,875 | 0 | $8.40M | $10.03M | 0.76% | +$1.63M |
| Apogee Therapeutics Inc | 70,000 | 70,000 | 0 | $5.89M | $9.29M | 0.70% | +$3.40M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 100,000 | +100,000 | $0 | $8.88M | 0.67% | +$8.88M |
| Cogent Biosciences, Inc.(COGT) | 225,000 | 225,000 | 0 | $8.66M | $8.71M | 0.66% | +$47.3K |
| Cytokinetics, Incorporated(CYTK) | 100,000 | 100,000 | 0 | $6.59M | $8.52M | 0.64% | +$1.93M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 450,000 | +450,000 | $0 | $8.42M | 0.63% | +$8.42M |
| Crescent Biopharma, Inc.(CBIO) | 453,686 | 453,686 | 0 | $8.33M | $8.17M | 0.62% | -$167.9K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 494,000 | 494,000 | 0 | $6.45M | $8.10M | 0.61% | +$1.65M |
| Kazia Therapeutics LimitedADS(KZIA) | 0 | 560,000 | +560,000 | $0 | $7.88M | 0.59% | +$7.88M |
| Shattuck Labs, Inc.(STTK) | 0 | 1,000,000 | +1,000,000 | $0 | $6.94M | 0.52% | +$6.94M |
| Avalo Therapeutics, Inc.(AVTX) | 300,000 | 375,000 | +75,000 | $4.48M | $6.93M | 0.52% | +$2.45M |
| Forte Biosciences Inc | 0 | 274,500 | +274,500 | $0 | $5.83M | 0.44% | +$5.83M |
| Relmada Therapeutics, Inc.(RLMD) | 842,106 | 842,106 | 0 | $5.86M | $5.83M | 0.44% | -$33.7K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 275,000 | 275,000 | 0 | $5.13M | $5.35M | 0.40% | +$228.3K |
| Zura Bio LimitedCL A(ZURA) | 900,000 | 900,000 | 0 | $5.36M | $5.31M | 0.40% | -$45.0K |
| Cybin D/B/A Helus Pharma(HELP) | 640,000 | 790,000 | +150,000 | $3.07M | $5.22M | 0.39% | +$2.15M |
| Odyssey Therapeutics Inc | 0 | 275,000 | +275,000 | $0 | $5.15M | 0.39% | +$5.15M |
| Immatics N.V.SHS(IMTX) | 0 | 475,000 | +475,000 | $0 | $4.81M | 0.36% | +$4.81M |
| Faeth Therapeutics, Inc.(FTH) | 0 | 180,505 | +180,505 | $0 | $4.51M | 0.34% | +$4.51M |
| Structure Therapeutics IncADS | 75,000 | 75,000 | 0 | $3.62M | $4.03M | 0.30% | +$410.3K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 176,500 | 350,000 | +173,500 | $2.24M | $3.79M | 0.29% | +$1.55M |
| An2 Therapeutics Inc | 749,035 | 749,035 | 0 | $2.56M | $3.63M | 0.27% | +$1.06M |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 2,000,000 | +2,000,000 | $0 | $3.40M | 0.26% | +$3.40M |
| Inovio Pharmaceuticals, Inc.(INO) | 2,370,122 | 2,844,994 | +474,872 | $4.12M | $3.13M | 0.24% | -$994.5K |
| Allogene Therapeutics Inc | 2,725,000 | 1,500,000 | -1,225,000 | $6.65M | $3.12M | 0.23% | -$3.53M |
| Solid Biosciences Inc | 300,000 | 300,000 | 0 | $2.16M | $3.00M | 0.23% | +$837.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 302,536 | 302,536 | 0 | $1.69M | $2.96M | 0.22% | +$1.27M |
| Clene Inc.(CLNN) | 477,515 | 477,515 | 0 | $2.35M | $2.94M | 0.22% | +$585.0K |
| Sarepta Therapeutics, Inc.(SRPT) | 150,000 | 150,000 | 0 | $3.26M | $2.70M | 0.20% | -$568.5K |
| MapLight Therapeutics, Inc.(MPLT) | 0 | 75,000 | +75,000 | $0 | $2.69M | 0.20% | +$2.69M |
| Nurix Therapeutics, Inc.(NRIX) | 100,000 | 100,000 | 0 | $1.55M | $2.43M | 0.18% | +$876.0K |
| LB Pharmaceuticals Inc(LBRX) | 70,000 | 70,000 | 0 | $1.73M | $2.27M | 0.17% | +$545.6K |
| Edesa Biotech, Inc.(EDSA) | 0 | 205,000 | +205,000 | $0 | $1.67M | 0.13% | +$1.67M |
| Invivyd, Inc.(IVVD) | 1,500,000 | 1,500,000 | 0 | $1.95M | $1.31M | 0.10% | -$641.4K |
| Upstream Bio, Inc.(UPB) | 150,000 | 150,000 | 0 | $1.35M | $1.04M | 0.08% | -$312.0K |
| Milestone Pharmaceuticals Inc.(MIST) | 666,666 | 666,666 | 0 | $793.3K | $893.3K | 0.07% | +$100.0K |
| PepGen Inc.(PEPG) | 272,892 | 272,892 | 0 | $483.0K | $491.2K | 0.04% | +$8.2K |
| REGENXBIO Inc.(RGNX) | 15,000 | 15,000 | 0 | $125.7K | $179.7K | 0.01% | +$54.0K |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 66,666 | 66,666 | 0 | $1.1K | $1.1K | 0.00% | $0 |
| Kalvista Pharmaceuticals Inc | 20,400 | 0 | -20,400 | $410.7K | $0 | — | -$410.7K |
| Soleno Therapeutics Inc | 200,000 | 0 | -200,000 | $6.70M | $0 | — | -$6.70M |
| Terns Pharmaceuticals Inc | 375,000 | 0 | -375,000 | $19.77M | $0 | — | -$19.77M |